Morning Briefing
Summaries of health policy coverage from major news organizations
Drug Makers Attract Scrutiny Over Cost And Ads, But May Benefit From Overhaul
Drug makers came under scrutiny at a Hill hearing after the AARP published research showing their wholesale prices had increased by an average of 9.3 percent over the last year, offsetting the value of the rebates to help seniors pay for drugs they promised to provide as part of the health care overhaul.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
